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Cardiovascular diseases (CVD) is now the main cause for death around the world. One of the 
major treatment to it is bypass grafting using a synthetic graft or patient’s own blood vessels to 
bypass the blocked area. However, the existing prosthetic graft for this surgery has poor long 
term patency, i.e. does not remain open for extended periods. The failure of existing graft is the 
result of platelet adhesion, which forms clots and then restricts blood flow. The purpose of this 
thesis is to introduce a new-generation synthetic graft which is flexible with an internal 
topography that changes continually due to normal pulse pressure oscillations. This thesis 
describes fabrication of such grafts, quantifies their expansion and contraction under pulsatile 
flow, and tests whether it reduces bio-fouling. The thesis also discusses the design strategy for 
such grafts so that they can work under certain pressure with a controlled deformation. Finally, 
we validate grafts with whole blood and platelet rich plasma to find out whether they reduce 
biofouling in vitro, also as a prelude to animal experiments. 
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1.0  INTRODUCTION 
Obesity, diabetes and smoking are leading to an increase in the population suffering from 
cardiovascular diseases (CVD) around the world, which causes more than 30% of worldwide 
deaths. [1]–[4]. Coronary and peripheral vascular diseases are very common among all types of 
CVDS. Coronary artery disease (CAD) refers to a plaque builds up inside the coronary 
arteries,[5], [6] and peripheral artery disease (PAD) is plaque inside arteries which reduces the 
supplement of blood flow for limbs and organs.[7], [8] 
 
 
Figure 1-1 Diagrams of CAD (left) and PAD (right) [6], [7] 
 
 As shown in Figure 1-1, there are blockages in blood vessel, which lead to insufficient blood 
supply downstream of the blockage.  There are many treatment to this kind of diseases, such as  
developing a heart-healthy lifestyle and medication.[5], [8]–[10]  However for many patients, 
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especially older ones with serious conditions, drug treatment usually has limited effect. [11] 
Bypass grafting is always considered as a general surgery to such blockages. Figure 1-2 shows a 
schematic of an above-knee bypass grafting. A conduit is implanted which bypasses the blocked 
artery, to ensure the supply of blood at downstream. 
 
 
Figure 1-2 Bypass grafting for PAD [12] 
 
Autologous grafts, i.e. blood vessels taken from the same patient, are the “ideal” material, due 
to its great accessibility (i.e. ease of use) and superior patency (i.e. ability to remain open). [13], 
[14] Patency is a very important factor when talking about bypass graft, it is the blood flow rate 
of normal part and blocked part (or where bypass graft locates) and normal part. Compared with 
synthetic graft which only maintain its patency of 39%, vein grafts remain a patency of 74% 
after 5 years.[15] However, roughly one third of patients, especially from the elderly population, 
do not have viable, autologous blood vessels, since they may have other vascular diseases or 
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their physical condition is not good enough to support such graft.[16], [17] Moreover, harvesting 
the patient’s vessels requires additional surgery, which can itself cause complications given that 
the patients (especially diabetics) suffer from poor wound healing. Finally, in some patients, the 
most desirable autologous vessels may already have been used up in previous bypass surgeries. 
For all these reasons, artificial grafts are desirable, and various synthetic grafts are available, 
made of materials  such as woven polyethylene terephthalate (PET) (also known as Dacron®), 
and expanded polytetrafluoroethylene (ePTFE).[18]–[20] Due to the lack of biocompatibility at 
the inner surface of these exiting grafts, thrombus forms on these surface, which leading to high 
failure rate of synthetic grafts.[21] These materials are very rigid compared to their host arteries, 
and their patency is poor when they are in low-flow areas, like below-knee, or with a small 
diameter (less than 6mm).[22]–[24] Some studies show that they tend to keep a good patency 
above-knee in large diameter surgeries, but patency is still far from satisfactory, and they also 
increase the risk of infection. [15], [25]  Over the past 40 years, surgeons have tried to develop a 
durable prosthetic graft, most importantly one that maintains a high-patency even when small 
diameter is needed. Some strategies to improve vascular grafts are to coat grafts with anti-
thrombotic drugs, or to develop other polymers for grafts. [26]  However, many challenges 
remain.  
Here we seek to develop prosthetic grafts that mimic one key feature of natural arteries. The 
luminal surface of muscular artery is always folded and form ridges hundreds of microns long.  
An in vitro study carried by Greensmith and Duling shows that the luminal surface of four 
muscular vascular with different initial diameter, they go to smooth and un-wrinkled when 
expanded, and back to folded when they get relaxed (shown in Figure 1-3). [27] This change in 
internal topography with pressure is a key feature that is missing in existing synthetic grafts. The 
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arterioles examined by Greensmith and Duling had a diameter range from 70 to 92 µm. 
However, it must be emphasized that for arteries with a larger diameter (such the arteries 
involved in typical vascular bypass surgeries), there is no physiological evidence for wrinkling-
unwrinkling with diameter changes. Nevertheless, they are heavily wrinkled when relaxed, and 
hence changes in surface texture with changes in diameter may happen in those cases as well.  
 
 
Figure 1-3 Four cross-section of arterioles at different expansion. A.125% of its original diameter (84 µm); B. 111% 
of 80 µm; C.72% of 92 µm; D. 34% of 70 µm[27] 
 
The idea being followed in this research is to build a graft to mimic this dynamic in which the 
inner surface is flat under expansion (high pressure), and wrinkled under constriction (low 
pressure). With this dynamic, surface biofouling may be avoided, thus allowing grafts to 
maintain patency for long time. If successful, this strategy could be applied to many existing 
polymers suitable for implanting in human body i.e. it is not dependent on any specific material 
chemistry. 
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2.0  BACKGROUND AND PREVIUOUS RESEARCH  
In this chapter, we will first describe some basic physics of wrinkling of thin films on soft 
substrate. It is the phenomenon that we exploit to create grafts with desired topography. Then 
previous research is reviewed. By this research, experiments are conducted to prove the 
hypothesis, and the different sizes of wavelength are also studied, which lays a foundation for 
future research.   
2.1 THIN FILM WRINKLING ON SOFT SUBSTRATES 
When a thin and stiff elastic film is attached to a pre-stretched softer elastic layer, it will buckle 
after the pre-stretch is removed (Figure 2-1). At its simplest, process can be regarded as 
minimizing the total elastic energy in these two layers, which is a sum of the bending energy of 
the stiff film, and the compression/stretching energy of the soft layer. [28]  
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Figure 2-1 Schematic of wrinkling formation in a bilayer system 
 
The central hypothesis of this research is that repeating a cycle of wrinkling and un-wrinkling 
could detach a fouling layer that sticks on the surface of the stiff film. Based on this, we develop 
the idea of a synthetic arterial graft composed of a multi-layered system, whose surface could be 
un-wrinkled when it is stretched and wrinkled when allowed to relax. This repeated smooth-
wrinkle process is expected to reduce adhesion of blood clots that foul the surface. The driving 
force for the stretching will be the pressure drop between systole and diastole blood pressure. As 
shown in Figure 2-2, a and b, the inner surface will be flattened and expanded under systole 
(high) blood pressure (150~mmHg). Figure 2-2, c and d show the inner surface will wrinkle and 
shrink under diastole (low) blood pressure (60~mmHg). The range of pressure mimics 
cardiovascular loads. Through this process, we hypothesize that surface adhesion can be reduced 
greatly, and an anti-biofouling inner surface may be achieved.  
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Figure 2-2 Schematic of inner surface under different pressure, and how a change in surface topography induces 
anti-fouling 
2.2 PREVIOUS PROOF-OF-CONCEPT EXPERIMENTS 
The basic idea of Figure 2-2 was validated in previous research by Dr. Luka Pocivavsek and 
Mr. Joseph Pugar. Flat-surface samples and wrinkled samples, with a wavelength of 50µm, were 
constructed by Polydimethylsilozane (PDMS). A bio-reactors were built which allow reversible 
wrinkling and un-wrinkling surface. Its schematic is shown in Figure 2-3. In this schematic, two 
black blocks are silicone actuator bases, the arched surfaces are samples adhered to the actuator 
base along its edges, the red colored part is where fresh ovine blood is located in the validation 
experiment. The driven force here is water pump underneath the test surface, alternately inflated 
between the actuated base and the other side of the sample, which balloons the sample to flatten 
a.         b. 
 
 
 
 
c.         d. 
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the test surface. Test surfaces were covered by fresh ovine blood at 37 ℃ for 90 minutes with 
actuation every 5 seconds.  
 
 
Figure 2-3 Schematic of a bio-reactor 
 
Samples were observed by Scanning Electron Microscopy (SEM) and quantified by Lactate 
dehydrogenase (LDH) assay for platelet adhesion and its density. For the non-actuated controls, 
the surfaces were submerged in fresh ovine blood, and rocked for 90 minutes’ incubation. By 
observing the non-actuated and actuated surfaces from SEM, it was found that actuated surfaces 
reduced adhesion greatly. The non-actuated wrinkled sample got the most platelet deposition due 
to its high surface area, non-actuated flat sample had the second-highest level of deposition on its 
surface. From the data gained by LDH assay, it was found that the actuated wrinkled surface 
decreased platelet adhesion nearly 97%. These results (which are a part of a paper to be 
submitted by Dr. Pocivavsek) strongly support the hypothesis (Figure 2-2) that a smooth-wrinkle 
transition reduces biofouling.  If a similar idea can be implemented in a cylindrical geometry, 
then prosthetic grafts based on this principle of anti-fouling based on topographic actuation could 
be obtained. 
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2.3 THE EFFECT OF WAVELENGTH 
Previous research by Dr. Pocivavsek also examined how the wavelength affects platelet 
adhesion. Geometries for the following experiments were all constructed by silicone-based 
crosslinked elastomers with specific curing agents, which are GI-245 (soft layer) and 
XIAMETER® RTV-4136-M (film). As shown in Figure 2-4, these multi-layer systems were first 
made flat in a rectangular shape, and then rolled in to a cylinder with 10cm in length and 6 mm 
in diameter. The seam was sutured together with 6-0 polypropylene suture, then sealed with GI-
245 at a very low thickness to prevent leaking.  
 
 
Figure 2-4 Schematic of constructing 1st generation graft  
 
To get actuation for these samples, they were sealed at two ends with a 5fr vascular access 
catheter (5fr indicates that the outer diameter of tis catheter is 1.667mm) insert inside (its tip is 
1mm away from the nearest cylinder end). Blood flow was output via a syringe pump, designed 
to provide a 2-3mL of blood at a frequency of 0.05Hz (Figure 2-5). Instead of ovine blood, 
whole blood provided by a healthy human was used immediately after collection. For every 
sample, syringe pumps were incubated at 37 ℃, and actuated for 90 minutes.  
10 
 
 
Figure 2-5 Sealed sample and how it was connected with syringe pump 
 
Typical graft structures were tested, one with a flat luminal surface, and three with different 
size of wavelength. They include one graft with a very large wavelength (λ = 1000 µm), one with 
a medium wavelength (λ = 250 µm), and the last one has a very small wavelength, 
approximately λ = 80 µm. Platelet deposition of all four were analyzed by LDH assay after blood 
exposure. Here, platelet density on the surface is indicated by ρ with a unit of platelet/mm2. 
The suture line showed significant clot formation in all samples and hence it was ignored. 
Thus, the sutureless half was studied. Based on the data collected by LDH assay, actuation was 
found to decrease platelet deposition (ρ) with a trend toward significantly decreased adhesion 
with smaller wavelength. On the other hand, there was no significant difference observed 
between flat and large wavelength samples, those with λ ≥ 1000 µm. Also, by comparing the 
platelet deposition on sample with a wavelength of 1000 µm, 250 µm and 80 µm, showed a clear 
and statistically significant decrease in platelet adhesion with decreasing wavelength. 
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2.4 DESIGN OF MULTI-LAYER SYSTEM 
As mentioned above, early samples prepared by Dr. Luka Pocivavsek were fabricated flat, and 
then sutured together to form a cylindrical geometry to mimic artery.  However, the suture line 
introduces highly thrombogenic area which clots heavily and hence a new method to prepare 
cylindrical samples without suturing is necessary. In this method, we follow a strategy of 
creating a tubular sample in which a thin stiff cylindrical film is attached to the inside of an 
inflated soft cylindrical tube. Upon relaxing the inflation, the soft tube shrinks, thus inducing 
wrinkles on the inner surface. This is illustrated in Figure 2-6 a and b. Detailed description will 
be given in next chapter. 
As discussed above, wavelength of graft greatly impacts the amount of platelet adhesion. 
Since we realize the wrinkles using the compression-induced buckling of a thin film on a soft 
substrate, we must examine how wavelength can be tuned in that situation. The wrinkle 
wavelength (λ) is related to the thickness (hf) of stiff membrane and the mechanical properties of 
two materials, which is described by scaling law [29]–[31]: 
   Equation 2-1 
 and  are the Young’s Moduli of film and substrate respectively and , 
where  is the Poisson’s ratio, which is 0.5. The subscripts f and s refer to the stiff film and soft 
substrate, respectively. Based on the data collected by Mr. Joseph Pugar, the modulus for the 
stiff layer and substrate layer respectively are and . With the 
desired wavelengths (λ), the needed thickness (hf) can be estimated easily. The pre-strain of the 
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substrate also affects the buckling phenomenon, but to a first approximation, it affects not the 
wavelength but the amplitude[29]:  
  Equation 2-2 
where is the strain, and  refers to critical strain for wrinkle formation, calculated by 
.  
Based on the conclusion from chapter 2.3, the desired wavelength is between 100 and 150 
microns. Applying in to equation 2-1, desired thickness ( ) could be got easily, which is in a 
range of 5-10 microns.  
In summary, the approach to graft design is to select the film and the substrate materials first, 
and then estimate the film thickness from the desired wavelength. The thickness of the softer 
layer is then selected based on other considerations, e.g. ease of suturing or manufacturing. 
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Figure 2-6 a-d are the schematic of graft with/without build-up layer at certain pressure; e is the stress analysis 
diagram when graft expanded at 20 kPa 
 
The materials to be used for the fabrication will be discussed later, however we found that at 
the desired pressure around 150 mmHg (20kPa), the cylinders expanded excessively as will be 
shown later in Figure 4-4. Accordingly, a stiffening layer was added to the outside of these two 
layers. As shown in Figure 2-6, a comparison of a-b vs c-d indicates how the stiffening -up layer 
changes the deformation of grafts. Figure 2-6 e, shows an elementary stress analysis of graft, 
orange arrows indicate for the inner pressure, which leads to the expansion of graft. Grey arrows 
are counter-acting forces in the cylinder walls (hoop stress) due to the expansion. During the 
fabrication procedure, the stiff film and soft substrate are made first to ensure the right 
wavelength is achieved, then the stiffening layer is coated to the outside of relaxed cylinder to 
restrict the deformation of graft under high pressure. The modulus of the stiffening material, also 
tested by Mr. Joseph Pugar, is Eb = 4.3MPa.  
Based on the stress analysis, we can write  
   Equation 2-3 
a       c 
 
 
b       d        e 
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Where, PH and PL refer to high and low pressure, which are 8kPa and 20kPa respectively 
(corresponding to systolic and diastolic pressures). D is diameter (4mm) of graft. Eb and Es are 
moduli of the build-up layer and the substrate, which are 4.3 MPa and 27.7 kPA respectively; hb 
and hs are thickness of these layers, and hs is 1.2mm; ε is the expected strain, which is 0.2. Here 
we assume that the innermost stiff film does not contribute significantly to the hoop stress since 
it is both very thin, and pre-buckled. 
By substituting moduli, pressure drop, initial inner diameter of 4mm, thickness of substrate, 
and expected strain, the desired thickness of the stiffening layer can be easily calculated, which 
is around 19 µm. 
A typical example of our graft is shown in Figure 2-7 (fabrication is described in the next 
chapter). The hf values appears to be close to 50 microns, much higher than the value of 
5microns calculated from equation 2-1 above. Nevertheless, the wavelengths were still on the 
order of 200 microns (see Figure 2-7). Thus, for reasons that are not clear, equation 2-1 is not 
able to predict the observed wavelength correctly in our experiments, yet, fortunately, we are still 
able to realize the desired wavelengths on the inner surface of grafts. 
Moreover, thickness of the stiffening (hb) can also be estimated to be 240 microns. Once 
again, this is far larger than the desired value estimated from Equation 2-3. Nevertheless, such 
grafts gave the desired strains of a few ten percent. Once again, there reasons for the discrepancy 
are not clear. This will be discussed further in chapter 6.  
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Figure 2-7 Microscopic picture of graft cross-section (a. thickness of stiffening layer; b wavelength; c thickness of 
film) 
a 
 
 
 
 
 
b 
 
 
 
 
 
c 
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3.0  CONSTRUCTING METHOD – FABRICATION  
To construct this cylindrical graft, the main method used is dip coating each layer, followed 
by bonding them together. All polymers used here are silicone-based thermoset elastomers with 
specific curing agents. Since silicones have high biocompatibility, good durability, flexibility and 
softness, these properties make it a good material to construct a vascular graft.  Also, they have a 
good chemically adhesive with each other, no additional reaction is needed when coating them 
layer by layer.  As judged by peeling experiments, uncured GI-245 has a good chemical adhesion 
on cured XIAMETER® RTV-4136-M (M-4), and uncured GI-380 shows a good curing on other 
silicone materials.  
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Figure 3-1 Texture analyzer instrument (used as dip coater) 
 
The uniformity of thickness of grafts is crucial to their performance in experiments. To 
control the thickness and realize wrinkles with small wavelength, a dip coater is needed. Instead 
of a standard dip coater, we are using used a Texture Analyzer instrument, which can provide the 
controlled-speed translation needed for dip coating (Figure 3-1). An acrylic rod can be fixed on 
the shaft of the instrument with a metal clamp, lowered into a bath of uncured silicone, and 
withdrawn. In our case, the bath consists of a centrifuge tube (of 12cm in length and 1.5cm in 
OD) filled with the uncured silicone to be coated onto the tube. Detailed information could be 
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found in table 3-1. It is worth noticing that for 1st /2nd layer of GI-245, the amount of 
crosslinker is been doubled. For polymer precursors, solvent is added proportionally to reduce 
the thickness of each layer, also crosslinker usually has a lower density than polymer. However, 
adding solvent could extend the curing time. In this case, double the amount could reduce the 
viscosity of the mixer and also accelerate the curing time. 
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Table 3-1 Material List 
Usage 
Silicone-
based 
polymer (A) 
Curing agent 
(B) 
Solvent (S) Ratio 
Diameter of 
rod/mm 
Curing 
time/hour 
Vendor 
1st /2nd layer 
of GI-245 
GI-245 
Ultra-Fast-
Curing 
crosslinker 
Hexane/n-
octane 
10A:2B:2S 3 8-12 Silicones, Inc. 
Membrane M-4* 
Specific 
crosslinker 
Hexane/n-
octane 
10A:1B:4S 6 8-12 XIAMETER 
Glue GI-245 
Standard 
crosslinker 
None 10A:2B - Max. 12 Silicones, Inc. 
Steady layer GI-380 
Specific 
crosslinker 
None 10A:1B - 8-12 Silicones, Inc. 
* XIAMETER® RTV-4136-M 
20 
  
Figure 3-2 Schematic of fabrication (cross-section of every step) 
 
The procedure is for preparing grafts, illustrated in Figure3-2, 3-3 and 3-4, is as follows:  
1. Dip coating 3mm Acrylic Rods with GI-245 at a speed of 4mm/s (see Figure 3-2 a and Figure 
3-3a). The ratio of base, crosslinker and solvent is 10:2:2. These rods need to be dipped twice 
with GI-245 with the same ratio to get the desired thickness. The crosslinker used here is the 
ultra-fast-curing one, and the optimal thickness of GI-245 is around 1-1.5mm after two coats 
(see Figure 3-4 a and b).  
2. Dip coating 6mm Acrylic Rods with XIAMETER® RTV-4136-M (M-4) at a speed of 0.4 
mm/s. The ratio of base, crosslinker and solvent is 10:1:4 (see Figure 3-2 b, 3-3 a and 3-4 c). 
3. Remove GI-245 tubes off the rod after the second layer has cured (see Figure 3-2 c).  
a. b. 
 
 
 
 
c. d. 
 
 
 
 
 e. 
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4. Prepare the silicone for the “glue” layer by mixing GI-245 with standard crosslinker in a ratio 
of 10:2, no solvent needed.  
5. Take the glue and dip one of the end of the M4-coated 6mm rod (Figure 3-2 d). Then insert 
the 6mm rod into the GI-245 tube, which will make the GI-245 tube stretched radially, 
without stretching it vertically (see Figure 3-4 d). 
6. After 10-12 hours to allow the glue layer to cure, remove the composite hollow cylinders off 
the rods (see Figure 3-2 e and Figure 3-5 a). 
After these steps, a graft with wavelength with a wavelength range from 50- 100μm will be 
achieved. The mean value of its wavelength is about 75μm, and) the diameter of this graft is 
about 5mm OD, and 3mm ID.  
For the in vitro experiments, the resulting grafts were found to be too soft, i.e. they underwent 
large expansion and compression under the typical pressure variations between systolic and 
diastolic pressure. Accordingly, they were coated with one further layer of a stiff silicone, GI-
380 on the outside as follows: 
7. Use a syringe cap with a diameter of 4mm, fit two of them to the two ends of hollow cylinder, 
close to the edge. Then, dip it into the GI-380 by hand. The ratio here is 10:1. Hang the 
cylinder for 8-12 hours to cure (see Figure 3-5 b). 
8. Repeat step 7 as needed. The number of GI-380 coats decided by the overall expected cylinder 
radial expansion. * Cut the cylinder off the caps. 
* The following in vitro experiment shows a good result with 2 coats of GI-380, the animal 
experiment works better with none or one coat.  
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Figure 3-3 a. dip coating 3mm rod with GI-245; b. dip coating 6mm rod with M-4 
  a        b  
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Figure 3-4 a. 3mm rod with one coat of GI-245; b. 3mm rod with two coats of GI-245; c 6mm rod with one coat of 
M-4; d. insert rod c in to GI-245 tube (peeled off from rod b)  
 
 
Figure 3-5 a. Original graft b. Graft coated with GI-380 (with syringe cap at each end to block GI-380 from leaking 
inside) 
 
a   b  c   d 
a         b 
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4.0  IN VITRO EXPERIMENTAL RESULTS 
Before blood fouling adhesion tests, cylinders need to be tested to find out whether and how 
much they expand under pressures and frequencies typical of real world applications. A series of 
pressure experiments were conducted. To mimic the actual situation of a real blood vessel, which 
is pumped by the heart, a pulsatile blood pump was used. This pump is Harvard Apparatus 
Pulsatile Blood Pump for Rabbits. It simulates the pumping action of the heart and generates a 
continuous pulsatile flow. Figure 4-2 shows the actual pump, and Figure 4-1 shows a schematic 
of the piston chamber.  
 
 
Figure 4-1 Schematic for piston chamber 
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As shown in Figure 4-2, the knob on the right is the rate adjustment knob, with a range from 0 
to 200 strokes per min. The knob on the left adjusts the stroke volume. Volume can be read from 
the decal fastened to the pump cylinder, determined by the “O” ring on the piston, shown in 
Figure 4-1. The volume can be adjusted while the pump is running. 
The piston chamber is connected to the external tubing via two one-way ball valves, one for 
the inlet and one for the outlet. For every stroke, the piston moves backward (to the right) first, 
and the negative pressure in the chamber lifts the metal ball near the entrance and liquid is 
sucked into the acrylic chamber. At the same time, the metal ball near the exit is forced closed. 
On the output stroke of the piston, the inlet ball closes whereas as the outlet opens, thus ejecting 
the fluid volume. Repeating the process described above, a pulsatile flow with certain rate and 
volume can be generated. 
 
 
Figure 4-2  Circulatory system (run with water) 
 
Since the actuation occurs on the luminal surface of grafts, and the thickness of the silicones 
under pulsatile flow is difficult to detect, a clinical vascular imaging technique called Optical 
Coherence Tomography (OCT) is applied. In Figure 4-3, there are two screenshots from a video 
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which recording the deformation of graft at the same position in vitro. The one on the left shows 
the cross-section of graft under low pressure, and the one on the right is the cross-section under 
high pressure. 
 
 
Figure 4-3 OCT of luminal surface of graft under low pressure (left) and high pressure (right) 
 
OCT works by using low-coherence interferometry, typically employing near-infrared light 
which can penetrate into the scattering medium, and collecting the images along the cross-
section at a high speed [32]. By moving the catheter back and forth within the tube, different 
locations can be imaged. The catheter (C7 DragonflyTM Imaging Catheter, LightLab) used 
could provide a resolution between 50-100µm.  
4.1 STRATEGY FOR RESTRICTING THE DEFORMATION OF GRAFTS 
Figure 4-4 illustrates the deformation behavior of a cylindrical graft at a pressure of 90mmHg in 
pulsatile flow at a frequency of 100 per minute. This graft has not been coated with a stiffening 
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layer of GI-380, and it is clear that the graft balloons up, i.e. the expansion strain is far higher 
than the 20% needed to drive the wrinkle-smooth transition. As explained in chapter 2.4, to 
restrict this expansion, a stiffer silicone, GI-380 is coated onto the outside of the graft. Its 
modulus is about 1000 times larger than GI-245. Note that M-4 is stiff as well, however since it 
has very small thickness, its effect on the gross mechanics of the tube can be ignored.   
 
 
Figure 4-4 Grafts without GI-380 coating ballooned at high frequency (100/min) and loose valve setting 
 
Equation 2-3 describes how the strain reduces as the thickness of the build-up layer increases. 
However, the optimal layer thickness was determined empirically. Grafts were coated externally 
with different number of coats of GI-380, and outer diameter at high pressure and low pressure 
were recorded. With the circulatory system, frequency was set to 60 and 80 strokes/min 
respectively, the maximum and minimum diameters recorded by video, for various number of 
stiffening coats, are shown in the graphical table 4-1. “LOD” and “HOD” stand for outer 
diameter at low pressure and outer diameter at high pressure. 
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From the table 4-1, for grafts without the GI-380 stiffening layer, the strain is too large even at 
low pressure suggesting that these grafts may not recovery to a wrinkled state even under low 
pressure. Grafts with 3 or 4 coats of GI-380 remain nearly static, i.e. there is not much 
deformation as pressure varies. Grafts dip coated with one layer of GI-380 tend to have an 
uneven coating, which may lead to leaking after pulsating for long time. As the number of coats 
of GI-380 increase, diameter of variation reduces and the pressure of variation increases.  And 
with a tight valve setting (3.4 and 3.6), the low pressure is not much impacted of different 
number of GI-380 coats, high pressure goes a little bit higher than the loose setting. 
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Table 4-1 Comparison diameter and pressure changes for grafts with various number of GI-380 coats 
Valve 
setting 
3.4&3.6 3.6&3.6 
60/min 
 
 
  
 
 
 
   
   
   
 
 
30 
Table 4-1 (continued) 
 
80/min   
  
 
31 
4.2 STRATEGY TO CONTROL THE PRESSURE DURING PULSATILE FLOW 
Due to pulsatile flow, we could control the pressure easily by two graduated valves at the end of 
the outflow. By constricting the valve to some value, the Tygon tube can be squeezed. Thus, a 
backpressure appears, and pressure upstream (in the graft) does not drop to zero immediately 
after the pump finishes its forward stroke. By setting the valve to different values, the desired 
pressure could be achieved.  
By using a pulsatile flow system shown in Figure 4-2, the cylinder is connected to the pump 
through Tygon tubes, and pressure is measured downstream with a pressure analyzer (Digi-Med 
Blood Pressure Analyzer (BPA-400)). 
To characterize the pressure-expansion behavior, a series of experiments were conducted. In 
these experiments, grafts with 0, 1, 2, 3, 4 coats of GI-380 were pulsated at frequency of 20, 40, 
60, 80, 90, 100, 110, 120. For one group, the valves are set to 3.4 and 3.6 (arbitrary graduations 
on the valve) separately. For another, valves are set to 3.6 and 3.6 respectively. It needs to be 
pointed out that a setting of 3.4 and 3.6 indicates a smaller tube diameter, i.e. a greater flow 
resistance. Furthermore, two valves are not necessary, in principle one is sufficient for the 
experiment. However, to get a finer control, two valves is applied. For every time, one graft with 
certain time of coats was tested, valves were set to certain value, and stroke volume for the pump 
was also fixed, which is 6mL. The only variable was the frequency with a range from 20 to 120 
strokes/min. 
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Table 4-2 Pressure measurements during pulsatile flow for grafts with various stiffening layers 
Valve 
setting 
3.4&3.6 3.6&3.6 
0 coat 
  
1 coat 
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Table 4-2 (continued) 
 
2 coats 
  
3 coats 
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Table 4-2 (continued) 
4 coats 
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Comparing these charts above, it can be found that high pressure could increase easily with 
tighter tube, especially after the frequency reaches 40/min, and pressure drops to zero at low 
frequency which indicates a full relaxation for the graft geometries. An interesting phenomenon 
can also be noticed that both high pressure and low pressure reaches the same value at the 
frequency of 100/min in every different experiment. According to the manual of pressure 
analyzer, its microprocessor samples at 1000 points/sec (a very high rate), and but the panel 
display updates only at every 0.5 seconds (according to specification of this pressure analyzer), 
so it may coincide with the change pattern of pressure, which could lead to this result here. Since 
the panel refresh rate is quite low, time for recording and tracking data is extended to ensure 
similar number came up repeatedly or this number is constrained in a relative narrow range. And 
these experiments were carried for several times, the results turn out to keep similar to each 
other. 
4.3 ANALYTIC MODEL 
A significant oddity of the above data is the convergence of the measured pressures at some 
frequency. As mentioned in the above paragraph, we believe that this is an artifact of the data 
refresh rate of the pressure analyzer. Nevertheless, we sought to develop a simple model to judge 
whether, under some simplifying assumptions, such convergence could appear.  
A simplified 1-dimensional model of this circulatory system (Figure 4-2) is shown in Figure 
4-5. This model assumes that the main flow resistance in the entire circuit is the valve itself; the 
remainder of the circuit offers very little flow resistance, and hence has uniform pressure. We 
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also assume that the graft is the only compliant portion of the circuit, whereas the remainder of 
the connecting tubing undergoes negligible volume change. 
The input Qin(t) is a square wave function, with period T. This can be written as 
  Equation 4-1 
Here , where Vc is stroke volume 6mL. Its plot is shown in Figure 4-5. The green 
block indicates a graft whose volume oscillates with time. The output flow is also a function of 
time Qout(t). 
 
  
Figure 4-5 Simplified model of circulatory system 
 
Here, volume of graft is a function of time , and a mass balance (assuming incompressibility 
of the liquid) gives  
  Equation 4-2 
The output flow rate Qout(t) can be written in terms of the gauge pressure (P) in the graft which 
drives the output flow, and the valve resistance, R, which regulates the flow. In principle, R is a 
function of flow rate, however here we will take it as a constant. 
  Equation 4-3 
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Strictly, the numerator of the above equation should be (P-Pdownstream), where Pdownstream is the 
pressure immediately downstream of the valve. We estimate that the downstream gauge pressure 
is close zero since the exit of the valve simply returns the fluid to a reservoir that is open to the 
atmosphere. In fact, the downstream gauge pressure is not zero since there is a few cm height 
differences between the valve and the reservoir. Yet, this small difference is ignored in this 
approximate analysis. 
The gauge pressure (P) is related to the current volume of graft; specifically, the more the 
graft is inflated (as compared to its zero-gauge-pressure value), the higher is the expected P. We 
introduce a constant (K), which represents the stiffness degree of the graft. And V0 is the initial 
volume of graft, which can be calculated by measuring the inner diameter and the length of graft. 
We then adopt a simple linear relationship between volumetric inflation and the gauge pressure: 
  Equation 4-4 
Combining equations 4-2,4-3 and 4-4,  
  Equation 4-5 
Where   is a constant with a unit of  and may be regarded as the rate at which an initially-
inflated graft deflates when the input flow rate is set to zero. And at t = 0, equation 4-5 can be 
written as: 
   Equation 4-6 
Subtracting equation 4-6 from equation 4-5, 
   Equation 4-7 
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Here, the bar notation indicates deviation variables, i.e. those that capture the deviation from the 
initial condition. Applying Laplace transform to this equation, 
   Equation 4-8 
where s is a complex variable.  
A MATLAB Simulink project was built on this equation 4-8 by Prof. Robert Parker (Figure 4-
6). 
 
 
Figure 4-6 Diagram of Simulink project 
 
In this project, input values are the initial volume of graft, input function  and deflation 
time . The output is the volume function of graft under preset conditions. 
The initial volume was set to 0.8792mL, based on the estimated diameter of 4mm and length 
of 7cm. 
We have not directly measured the deflation time. Nevertheless, since the graft visibly 
expands and contracts at a oscillation frequency of 100 strokes/min, deflation times must be well 
under 1 second. For illustration purposes, the deflation time is set to 0.1s, and frequency is set to 
be 20, 40, 60, 80 and 100 strokes/min. Due to different frequency, input function Qin(t) has 
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different period ( and different maximum value , where Vc is stroke 
volume 6mL. 
The results are plotted in Figure 4-7 and Figure 4-8 below. A higher frequency can lead to an 
incomplete relaxation of graft (i.e. the volume remains higher than  throughout the oscillatory 
cycle), which is clearly shown in Figure 4-7. A higher frequency also indicates a larger volume 
variation, which can be considered as a larger diameter variation, over each cycle. From equation 
4-4, pressure is proportional to , which is the deviation of volume from the deflated 
volume. Furthermore, since R is held constant, the pressure is proportional to . 
From Figure 4-8, the difference between the maximum and minimum volume can be obtained, 
and the quantity  plotted against frequency, as shown in Figure 4-9. The same 
tendency can be found that change volume at maximum and minimum increase, indicating that 
high pressure and low pressure both increase with a higher frequency. This this simple model at 
least suggests no mechanism whereby the high and low pressures in the graft would converge. 
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Figure 4-7 Volume function with frequency at 60 and 180 strokes/min 
 
  
 Figure 4-8 Volume function with frequency at 60, 80, 100 and 120 strokes/min  
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Figure 4-9 Diagram of   vs. frequency 
 
The ratio K/R, indicates the deflation time of the graft. Under the frequency of 80 strokes/min, 
 is assigned to be 0.033, 0.1 and 0.3 seconds. Figure 4-10 plots the volume vs. time for these 
conditions. For each condition, the quantity  plotted against frequency is shown in 
Figure 4-11. And it can be found that that ratio of K and R does not change the result 
qualitatively, but grafts that deflate rapidly reach the fully-relaxed volume during the deflation 
phase of the cycle. 
 
 
Figure 4-10 Volume vs. time at 80 strokes/min (R/K = 0.033, 0.1 and 0.3s)  
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Figure 4-11 Diagram of   vs. frequency 
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Several comments are needed regarding the assumptions of the model. This 1-dimensional 
model assumes the flow can be regarded as quasi-static. Strictly speaking, inertial effects due to 
the pulsatile motion may also play a role. This can be judged by evaluating the, Womersley 
number, ,[33] 
   Equation 4-9 
Where L is radius of this graft/tube,  is the frequency in radius, and  is the kinematic viscosity 
of the fluid, which is water here. Substituting the diameter 2mm, frequency  and 
kinematic viscosity of water , and Womersley number is 2.89 when frequency is 
80 strokes per minute. Thus, this flow cannot be regard as strictly “quasi-steady”. 
We have also assumed that graft is the only compliant element in the circuit and the volume 
changes of the tubing is negligible. Using the diameter of tygon tube of 6.35 mm and length at 40 
cm, volume of tube can be calculated, which is around 12.7 cm2. Visually at least, the compliant 
tubing does not undergo significant changes in dimension. Even if we assume that the tubing 
undergoes up to 1% change in volume under the pulsatile flow conditions, this corresponds to 
0.12 mL of the volume change. The grafts undergo diameter changes on the order of 10% or 
more, and hence volume changes on the order of 20%, which corresponds to roughly 0.17 mL. 
Thus, even small percentage volume changes of the tubing may give rise to volume fluctuations 
that are comparable to the graft fluctuations. Thus, the assumption that the entire compliance of 
the flow circuit is in the tubing must be verified by directly measuring the compliance of the 
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tubing. Finally, we have assumed that the main resistance to flow is the valve. To get the friction 
resistance, Reynold number, Re, indicating the flow pattern, needs to be given.[34] 
  Equation 4-10 
Where, is a characteristic velocity, and  is a characteristic length.  is the density of the 
fluid and  is its dynamic viscosity. Equation 4-10 can also be written as, 
   Equation 4-11 
By substituting the flow rate of fluid Q, which is 24mL/s for maximum under 80 strokes/min; 
kinematic viscosity, , (the ratio of the dynamic viscosity to the density of the fluid), which for 
water at 25℃ is ; and the diameter of the tube D (6.35mm). Reynolds 
number is 4798 for this condition. Through Blasius formula [34], [35], friction factor can be 
estimated, 
   Equation 4-12 
f is  for the tygon tube. Hence the pressure gradient can be calculated as, [34] 
   Equation 4-13 
Here,  is the mass rate, which is 8 g/s for the average of this fluid. The result from equation 4-
13, is   . For tube with a length of 40 cm, the total pressure drop is 0.57 
mmHg which is a small fraction of the total pressure drop which is several tens of mm of Hg. 
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As to the local resistance from the valve, the fluid flow experiences a change in cross-section 
area, which is 31.65 mm2 for the tubing to less than 7 mm2 for the valve. It can be simplified to a 
model that fluid flow through a thin orifice, shown in Figure 4-12. From handbook,  discharge 
coefficient (Cd) for this orifice is 0.6.[36]–[38]  
 
 
Figure 4-12 Flow through orifice 
 
By applying Bernoulli’s equation to cross section a (orifice upstream) and cross-section b 
(orifice downstream), should obtain, 
   Equation 4-14 
P is the static pressure, v is the average velocity at this two section. Since inlet and out let flow 
rate are the same, which is, . Furthermore, the area of section “o” and 
section “b” is much smaller than inlet area “a”, so the velocity in section “a” ( ) is neglected. 
Simplifying equation 4-14, one get [39]–[42] 
  Equation 4-15 
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Subsisting the density of water at 25℃, which is 1000kg/m3; Average flow rate, 8 mL/s; Cd is 
0.6, Ao is 7 mm
2, the pressure drop through this orifice is 1814 Pa, which is 13 mmHg. By 
comparing the friction resistance from the tube and local resistance from the valve, one can 
conclude that the resistance for the tube can be neglected. Thus, the assumption that the main 
resistance to flow is from the valve appears to be justified. 
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5.0  VALIDATION EXPERIMENT 
Although the idea that changes in surface topography could eliminate clots driven by pressure 
drop was authenticated by previous experiments by Dr. Pocivavsek, the graft developed in this 
project has not yet been validated to reduce blood fouling.  To test whether the graft could 
function well and decrease biofouling deposition, a liquid which can show bio-fouling is needed. 
Here, bovine whole blood and expired platelet-rich plasma (PRP) is used. PRP is plasma with 3-
8 times the concentration of normal platelet levels (150,000 to 400,000 platelets per microliter), 
and contains almost none of other kind of blood cells. The concentration of platelets and growth 
factors can be 5 to 10 times greater (or richer) than usual.[43], [44] Platelets are very important 
to blood clotting. The activation of platelets can trigger the activation of more than 30 
substances, most of them are proteins. Together they build up clots and prevent blood loss from 
wounds.[45], [46] Although the PRP used here is expired, platelets still have a sufficient activity 
that they can adhere, aggregate and build clots. However, it could take hours, even days for 
platelets clotting by themselves. To accelerate this process, a small amount of thrombin (from 
human plasma) is added to the PRP before the start of the experiment. Detailed information of 
materials and solutions are listed in Table 5-1. The effect of thrombin is shown in Figure 5-1, 
one dish contains only PRP (25 ml), and the other one has the same amount of PRP, but with 
30μL of thrombin stock solution, which contains 3 units of thrombin. After two hours at room 
temperature, there are obvious flocs in the PRP with thrombin, and no significant change to 
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thrombin-free PRP added. We presume that these flocs formed by activated platelets and other 
proteins. Due to the high-activity of thrombin, quantity of it need to be controlled. Too much of 
thrombin will lead to a high viscosity of liquid and also blockage in the system, which will 
damage the pump. However, less thrombin may take a long time for clot formation, and clots 
adhere to luminal surface might be less, which could impact the result. To Figure the necessary 
quantity of thrombin, various amount (3, 5, 10 and 20 units) of thrombin were added into 25mL 
of PRP, coagulation time is recorded.  Under room temperature, expired PRP with 10 and 20 
units formed a gel-like block within 1 minute. For those with 3 and 5 units, it took over 50 mins 
and 10mins respectively.  
 
 
Figure 5-1 Comparision of 25 mL expired PRP with none (left) and 3 units (right) of thrombin after 2h at room 
temperature 
 
To test that actuation of the grafts reduces clot adhesion, a control sample (which does not 
pulsate) is needed. This control sample is made by coating several GI-380 stiffening layers on 
the outside of the cylinder, and then further immobilized by adhesive tape. However, the control 
has the similar luminal surface wrinkled topography as the test sample. In this case, it will 
remain rigid during the pulsatile flow experiment.  
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Table 5-1 Detailed information of materials and solutions 
Name Concentration 
Amount (per 
experiment) 
Vendor Notes 
Thrombin stock solution 
100 units/ml in 0.1% (w/v) BSA 
solution 
300 μL EMD Millipore 
For PRP 
experiment 
Thrombin stock solution 
100 units/ml in 0.1% (w/v) BSA 
solution 
400 μL EMD Millipore 
For whole 
blood 
experiment 
Bovine Whole blood in 
Sodium Heparin 
N/A ~250mL 
Lampire Biological 
Laboratories 
Consumed 
13 after 
bleed date 
Expired PRP 150,000 to 400,000 platelets /mL ~250mL Central Blood Bank 
Consumed 
within a 
week after 
expire date 
Wright stain solution N/A ~10mL Fisherbrand 
Dark 
Purple 
4% Buffered Formalin solution 
40g of paraformaldehyde in 1L 
1X PBS solution 
~100mL PROTOCOL  
PBS without Calcium or 
Magnesium 
1X PBS solution ~50mL Lonza  
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Figure 5-2 Circulatory system run with expired PRP 
 
The two samples were connected by a Tygon tube in series, and expired PRP (3 bags, about 
250ml) with 300μL thrombin stock solution (corresponding to 30 units of thrombin) added was 
held in a 250ml - glass media bottle, immersed in a water bath at 37C. 
The pulsatile flow experiment was run at rate of 80 stokes/minute over 4hours. At the end of 
the experiment, the two grafts were cut off from this circulatory system. They were rinsed with 
Phosphate Buffered Saline (PBS) solution gently to remove the extra clots not attaching to the 
surface. After rinsing 3~5 times, the samples were soaked in 4% Buffered Formalin solution to 
complete the fixation of protein and cells (thrombus patch) for 24 hours at room temperature. For 
following staining process, fixation is very important, since it could stabilize the clots and 
protect samples against microbial contamination and decomposition, thus permitting ex-situ 
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imaging. To get a better view of the inside, grafts were cut from the middle. For staining the clot, 
two grafts were bisected in half along their axis creating two equal hemicylinders, which allow 
the inside surface to have a better contact with Wright-Giemsa stain. Wright-Giemsa stain is 
commonly used for blood smears, usually blood cells present a color of purple.[47] The actual 
procedure for used staining with Wright-Giemsa stain has been listed in the Appendix B. Clots 
color in dark purple after stain. As shown in Figure 19, the difference of the fouling situation 
between two grafts is apparent to even to naked eyes. There is a large clot forming in the static 
graft (Figure 5-3), which even blocked the whole flow circuit; So, the controlled sampled had to 
be removed 30 mins earlier than planned. As to the actuated graft, there is much less clot 
forming in it. With a closer look for these two grafts (Figure 5-4), further significant difference 
could be identified: the actuated sample maintained a relative clean surface with much less 
platelet deposition on its surface. By contrast, more clots attached to the inner surface of static 
sample, which was heavily contaminated within four hours. Same experiments were conducted 
for 4 times and similar result is achieved. 
 
  
Figure 5-3 Luminal surface of actuated graft (left) and static graft (right) with PRP 
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Figure 5-4 Luminal surface of actuated graft (left column) and static graft (right column) with PRP 
 
Besides running with PRP, whole blood (see table 5-1 for details) is also introduced to this 
process. Two samples were run by bovine whole blood (250mL) and 400μL of thrombin stock 
solution (40 units of thrombin). Since anticoagulant was added to whole blood, the amount of 
thrombin was necessary to complete the experiment in a reasonable time. The viscosity of whole 
blood is 3-5 times than the viscosity of PRP[48], and it is much more rich in blood cells and 
proteins. The clot forming speed was much higher than PRP, and so the viscosity increases as 
well. Due to these two factors, this experiment was only run for 1.5 hours. The remaining 
experimental conditions remained the same as for the PRP experiment. The results are shown in 
Figure 5-5 and 5-6. Even with the shorter time, the difference between actuated and static grafts 
remain.  
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Thus, is clearly that luminal surface remains cleaner when it is actuated, which indicates that 
grafts could function well with PRP and whole blood under expected pressure. 
 
 
Figure 5-5 Luminal surface of actuated graft (left) and static graft (right) with Bovine whole blood 
 
 
Figure 5-6 Luminal surface of actuated graft (left column) and static graft (right column) with bovine whole blood 
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6.0  SUMMARY AND PERSPECTIVES 
From what has been discussed above, this featured graft with small diameter (<6mm) function 
well under desired pressure range. Following animal experiments also proved that its luminal 
surface is qualified as self-clean when actuated. However, there are still lots questions needed to 
be solved. 
 The first problem countered is the huge mismatch between calculation and measurement. 
Reasons for this discord may be the mismeasurement of moduli, or materials show different 
physical properties when they are prepared differently. And there are expiration dates for each of 
these silicone-based polymer, they might deteriorate after some time, also still within the 
recommended date. This deterioration may lead to an increasing or a decreasing in stiffness of 
polymers.  
Second problem is the phenomenon that low pressure and high pressure appear to overlap 
with each other at 100 per minute.  One possible reason guess for this is that this is an artifact of 
the display frequency of sensor panel being close to consistent with the pattern of pressure 
change, in this case, pressure appears to keep at the almost the same values.  A higher frequency 
pressure measurement could be applied for further study to fix this problem.  
Third is the assumption that the volume changes of the tubing are negligible. However, 
through calculations it is found that a small percentage volume changes of the tubing may give 
rise to volume fluctuations that are comparable to the graft fluctuations. In this case, the 
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assumption that the entire compliance of the flow circuit is in the tubing must be verified by 
directly measuring the compliance of the tubing. Or these tygon tubes could be replaced by other 
kind of tubes, which are more rigid, like metal tubes.  
There are also some improvements. As discussed in chapter 2.2, another than actuated 
wrinkled sample, the actuated flat sample also shows a good performance in reducing bio-
fouling. However, in validation experiment, actuated flat graft is not tested. For the integrity for 
this research, actuated flat sample needs to be tested as well. Then, the graft length needs to be 
increased for practical applications. Current graft length is about 7 cm in average (Figure 3-5a). 
For surgeries, the optimal length is over 10cm. However, it is limited by current construction 
strategy, especially by the tools used. Thus, fabrication method should be improved in order to 
increase graft length. Indeed ideally, it would be desirable to manufacture continuous graft 
tubing that can be cut to the desired lengthy the surgeon. The instrument used as dip coater could 
be transformed, in order to provide more vertical work space. Although initial success is 
obtained, this graft has never been tested over 5 hours. Long-term experiments, counted by days, 
should be applied, to find out its durability and performance in a relatively long time.  
Previously Dr. Pocivavsek studied the influence of the size of wavelength in chapter 2.3, and 
found that a smaller wavelength could give less platelet deposition. However, we have not 
studied wavelength effects our blood or PRP experiments. When the wavelength is small enough 
(e.g. sub-micron), we may expect the luminal surface could be “effectively” flat, i.e. the platelets 
or the platelet clots would no longer be able to “see” the change from smooth to rough. In this 
case, we anticipate graft will not reduce bio-fouling.  To know the right range of wavelength, 
fabrication method need to be improved, and grafts with small wavelength, much less than 80 
microns, should be studied. 
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For the future study, current materials are enough for carry in vitro experiments and tests. 
However, when it comes to in vivo experiments or surgeries, it needs to be replaced by other 
material which is easier for human bodies to tolerate, and maintain its feature for long-term, and 
FDA approved.  
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APPENDIX A  
 
 
 
 
DIAGRAM OF STRESS-STRAIN 
 
 
 
 
Following data was collected by Mr. Joseph Pugar. Polymers were constructed into a dog bone-
shape batch, then tested with standard multicycle tensile test.  
Graph of stress-strain of all polymers were shown below. 
 
  
Figure A.1 Stress-strain of GI-380 with 10%(w/w) crosslinker added 
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Figure A.2 Stress-strain of M-4 with 10%(w/w) crosslinker added 
Figure A.1 and A.2 are diagram of GI-380 and M-4, when 10% (w/w) of crosslinker is added. 
After applying with a linear fitting, two linear function could be calculated. And slopes of these 
two function are the moduli of GI-380 and M-4 respectively.  
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Figure A.3 Stress-strain of GI-245 with 10%(w/w) crosslinker added 
 
 
Figure A.4 Stress-strain of GI-245 with 30%(w/w) crosslinker added 
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In Chapter 3, 20% of crosslinker is added to GI-245 to construct substrate.  However, moduli of 
GI-245 with 10% and 30% crosslinker is tested, which are 26831 and 28620 Pa respectively. In 
this case, modulus of GI-245 with 20% of crosslinker is decided to be intermediate value of these 
two numbers, which is 27.7 kPa. 
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APPENDIX B 
 
 
 
 
STAIN PROCEDURE 
 
 
 
 
 
1. Take one buffer tablet. Dissolve it with 1000 mL deionized water. 
2. Put the bisected graft into a glass petri dish, with a diameter of 10 cm. Fixing the graft with 
Methyl Alcohol for 60 seconds. Remove the excess methanol from the dish. 
3. Cover the graft with 3 mL of Wright-Giemsa stain and allow to stain for 2 minutes. 
4. Add 4.5 mL of PH 6.4 Diluted Buffer to the stain-covered graft. 
5. By rocking the dish genteelly to mix the stain and buffer solution together about 1 minute. 
Leave the mixture to stain the graft for an additional 3 minutes. 
6. Rinse the graft with PBS solution and allow it to air dry. 
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